The newborn feels pain and the newborn at the end of life, in the delivery room, is potentially exposed to pain and respiratory distress.

Protocols for the management of end-of-life symptoms in the delivery room are used in current practice with very few validation studies. The protocol used in delivery rooms in Alsace uses fentanyl and midazolam intranasally. It has been used for 3 years and seems to provide satisfactory relief to newborn babies. In doing so, it seems to reassure parents about the quality of support and it seems to meet the expectations of professionals in these anxiety-provoking contexts. Scientific validation of these practices would allow wider dissemination to other maternity teams.

Inclusion Criteria:

• Premature or term newborn
• In the delivery room
• In palliative care
• No parental opposition to data collection

Exclusion Criteria:

• Parental refusal or inability to express their consent
• Minor parents
• Very probable survival beyond the delivery room
• Impossibility of giving informed information to the subject (subject in an emergency situation, difficulties in understanding the subject, etc.)
• Subject under safeguard of justice
• Subject under guardianship or curatorship

Premature or term newborn in the delivery room